Drug · DIN 02421089
ZALTRAP
CONCENTRATE FOR SOLUTION. FOR I.V. INFUSION. 25 MG/ML SINGLE USE VIALS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 13, 2020; first marketed May 8, 2014.
- Drug Identification Number (DIN)
- 02421089
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Aflibercept L01XX44
- Class
- Human
- Record last updated
- August 28, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AFLIBERCEPT | 200 MG | 8 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 12, 2014: NOC 15245New Drug Submission (NDS)
Other DINs named ZALTRAP
- DIN 02421070 · Cancelled Post Market